Maplelane Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-160,000	Closed	-$8.18M	–	65
2024 Q3	$8.18M	Hold	160,000	–	–	0.47%	32
2024 Q2	$7.17M	Buy	+160,000	New	+$7.17M	0.25%	37